[
  {
    "ts": null,
    "headline": "Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
    "url": "https://finnhub.io/api/news?id=73d8633fe73031827e09922ce585b40aa78c6bbae474347c4f64a38757c617b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741804190,
      "headline": "Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds?",
      "id": 133186687,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
      "url": "https://finnhub.io/api/news?id=73d8633fe73031827e09922ce585b40aa78c6bbae474347c4f64a38757c617b0"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a0fbe84336b26b75948ad7cc0b08876e3c26673cbe7d5d8a3ebc714370527cea",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741797720,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "id": 133222590,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a0fbe84336b26b75948ad7cc0b08876e3c26673cbe7d5d8a3ebc714370527cea"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
    "summary": "Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=f297b0f96ecf5627c1bb5d0f1adf3831195761050b8de52bda165ebfa870c982",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741793414,
      "headline": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
      "id": 133185498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=f297b0f96ecf5627c1bb5d0f1adf3831195761050b8de52bda165ebfa870c982"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Summit Fund Q4 2024 Commentary",
    "summary": "The fund outperformed its benchmark and peers for the final quarter and full year 2024, driven by positive stock selection.",
    "url": "https://finnhub.io/api/news?id=b6b7a9b04968ef2dc0344a2d4b9eee78d705f6cf8640e8b584642a4d569b9f25",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741777200,
      "headline": "Invesco Summit Fund Q4 2024 Commentary",
      "id": 133149564,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2149067144/image_2149067144.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "The fund outperformed its benchmark and peers for the final quarter and full year 2024, driven by positive stock selection.",
      "url": "https://finnhub.io/api/news?id=b6b7a9b04968ef2dc0344a2d4b9eee78d705f6cf8640e8b584642a4d569b9f25"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem",
    "summary": "Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Matteo Paz, 18, of Pasadena, California, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.'s oldest and most prestigious science and math competition for high school seniors.",
    "url": "https://finnhub.io/api/news?id=b81e8d29e38f07a2559623b74de4218f1a545ca9ff89f52814cae3225dbaa957",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741747800,
      "headline": "Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem",
      "id": 133186689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Matteo Paz, 18, of Pasadena, California, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.'s oldest and most prestigious science and math competition for high school seniors.",
      "url": "https://finnhub.io/api/news?id=b81e8d29e38f07a2559623b74de4218f1a545ca9ff89f52814cae3225dbaa957"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem",
    "summary": "$250,000 top award goes to Matteo Paz in America’s longest running and most distinguished science and math competitionTARRYTOWN, N.Y. and WASHINGTON, March 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s oldest and most prestigious science and math competition for high school seniors. Now in its 84th",
    "url": "https://finnhub.io/api/news?id=6ab3987e360dd77b2070dc006da1cc6fdbd763dedea17275ecd8629db84b160e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741743120,
      "headline": "Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem",
      "id": 133186690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "$250,000 top award goes to Matteo Paz in America’s longest running and most distinguished science and math competitionTARRYTOWN, N.Y. and WASHINGTON, March 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s oldest and most prestigious science and math competition for high school seniors. Now in its 84th",
      "url": "https://finnhub.io/api/news?id=6ab3987e360dd77b2070dc006da1cc6fdbd763dedea17275ecd8629db84b160e"
    }
  }
]